Molecular Mechanism and Therapeutic Opportunities of Breast Cancer
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 5 June 2025 | Viewed by 990
Special Issue Editor
Interests: biochemistry; GPCR signaling; molecular pharmacology; molecular mechanisms of pharmacological action; cell biology; cancer research; drug design
Special Issue Information
Dear Colleagues,
Breast cancer is one of the most frequent cancers worldwide and is characterized by multifactorial etiology and genetic heterogeneity. Molecular mechanisms involved in its pathogenesis include imbalances in cell signaling, metabolism, and stress responses, as well as gene dysfunction. Recent studies have identified new target molecules such as hormone receptors, human epidermal growth factor receptors, and molecular pathways related to cancer cell survival and metastasis. These findings have led to innovative therapeutic strategies, such as targeted antibody therapies, macromolecular and micromolecular inhibitors, and immunotherapies. Personalized medicine based on genomic and tumor profiling offers promising prospects for improving prognosis and reducing side effects. But tackling tumor resistance to treatment and understanding its mechanics is a far greater challenge. As part of the Special Issue, papers could be published that focus on topics such as novel molecular mechanisms involved in the development and progression of breast cancer, targeted therapies, molecular biomarkers, use of genomic analysis for personalized therapy and treatment decisions, immunotherapy, and mechanisms of resistance development, as well as issues related to drug resistance and relapse, and innovative methods for the diagnosis and monitoring of breast cancer.
Dr. Athanasios A. Panagiotopoulos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- molecular mechanisms
- targeted therapy
- genomic profiling
- hormone receptors
- tumor microenvironment
- immunotherapy
- drug resistance
- metastasis
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
